logo
Share SHARE
FONT-SIZE Plus   Neg

Reports: Pfizer Likely To Pick Buyer For Infant-nutrition Unit Next Week

Pharmaceutical giant Pfizer Inc. (PFE) is close to a deal to sell its infant-nutrition unit and an announcement could be made as early as next week, reports said Tuesday.

Switzerland-based Nestle SA (NSTR.L, NSRGY.PK) is said to be likely to win the bid for the unit that makes baby formula and maternal supplements, according to a report in the Wall Street Journal which said the deal price was at least $9 billion.

Pfizer had received bids from Nestle and France's Danone SA (DANOY.PK), each worth about $10 billion, Bloomberg said. Danone made a joint bid with Mead Johnson Nutrition Co. (MJN) and a third bidder is no longer in the running.

The report added that Danone said it is not likely to win the bid. Pfizer is said to be keeping Danone in the bidding process.

It was reported in February that Nestle and Danone were trying to overcome antitrust problems in the deal.

Meanwhile, Pfizer is said to be planning an initial public offering for its animal health unit. The drugmaker has hired JPMorgan Chase & Co., Bank of America Corp. and Morgan Stanley to aid in the transaction.

PFE closed Tuesday's regular trade at $22.31, up $0.33, on 29.1 million shares.

Nestle closed up by 1.33 percent at 56.75 Swiss francs on a volume of 6 million shares.

Danone settled in Paris higher by 2.90 percent at 53.08 euros on 3.36 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Tesla's next electric car Model 3 is aimed at the masses with a price tag that could go below $30,000. Tesla CEO Elon Musk, during an earnings call, confirmed that the Model 3 will start selling for "around $35k," and reservations will start from March 31 in Tesla stores and online on April 1 for... Advanced Disposal Services Inc. joins the growing list of companies to postpone their initial public offering amid the volatility in stock markets. Breakfast and snack food giant Kellogg Co. on Thursday reported a loss for the fourth quarter that narrowed from last year as lower revenues were more than offset by a decline in costs and expenses. Adjusted earnings per share for the quarter topped analysts' estimates, while revenue fell short of expectations. Looking ahead, the company affirmed its financial outlook for fiscal 2016.
comments powered by Disqus
RELATED NEWS
Trade PFE now with 
Follow RTT